Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Meerbeeck

Showing results (111-120 of 250) with videos related to

Pageof 25
Sort By:
Acta Clinica Belgica|April 15, 2014
Routine implementation of EGFR mutation testing in clinical practice in Flanders: 'HERMES' projectA Janssens, E De Droogh, A Lefebure, et al.
Journal of Breath Research|June 30, 2020
The scent of COVID-19: viral (semi-)volatiles as fast diagnostic biomarkers?Kevin Lamote, Eline Janssens, Eline Schillebeeckx, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Real-life treatment practice for malignant pleural mesothelioma in BelgiumMichael Rosskamp, Gilles Macq, Kristiaan Nackaerts, et al.
Lung Cancer (Amsterdam, Netherlands)|June 6, 2015
Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and EnglandR A Damhuis, A Khakwani, H De Schutter, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Assessing the completeness and correctness of the registration of malignant mesothelioma in BelgiumMichael Rosskamp, Harlinde De Schutter, Kris Henau, et al.
Rehabilitation Research and Practice|November 24, 2011
Endurance and Resistance Training in Radically Treated Respiratory Cancer patients: A Pilot StudyB Salhi, I Demedts, A Simpelaere, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 14, 2026
Hypoxia induces alterations in the volatile signature of pleural mesothelioma cellsEline Janssens, Ellen Heirwegh, An Wouters, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic reviewYoussef Ben Bouazza, Ibrahim Chiairi, Ouiam El Kharbouchi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2009
Targeted therapies in the treatment of advanced/metastatic NSCLCA G Pallis, L Serfass, R Dziadziusko, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2008
The yield of endoscopic ultrasound in lung cancer staging: does lymph node size matter?Kurt G Tournoy, Frédéric De Ryck, Lieve Vanwalleghem, et al.
Pageof 25

Showing results (111-120 of 250) with videos related to

Sort By:
Pageof 25
Acta Clinica Belgica|April 15, 2014
Routine implementation of EGFR mutation testing in clinical practice in Flanders: 'HERMES' projectA Janssens, E De Droogh, A Lefebure, et al.
Journal of Breath Research|June 30, 2020
The scent of COVID-19: viral (semi-)volatiles as fast diagnostic biomarkers?Kevin Lamote, Eline Janssens, Eline Schillebeeckx, et al.
Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Real-life treatment practice for malignant pleural mesothelioma in BelgiumMichael Rosskamp, Gilles Macq, Kristiaan Nackaerts, et al.
Lung Cancer (Amsterdam, Netherlands)|June 6, 2015
Treatment patterns and survival analysis in 9014 patients with malignant pleural mesothelioma from Belgium, the Netherlands and EnglandR A Damhuis, A Khakwani, H De Schutter, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Assessing the completeness and correctness of the registration of malignant mesothelioma in BelgiumMichael Rosskamp, Harlinde De Schutter, Kris Henau, et al.
Rehabilitation Research and Practice|November 24, 2011
Endurance and Resistance Training in Radically Treated Respiratory Cancer patients: A Pilot StudyB Salhi, I Demedts, A Simpelaere, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 14, 2026
Hypoxia induces alterations in the volatile signature of pleural mesothelioma cellsEline Janssens, Ellen Heirwegh, An Wouters, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic reviewYoussef Ben Bouazza, Ibrahim Chiairi, Ouiam El Kharbouchi, et al.
European Journal of Cancer (Oxford, England : 1990)|July 15, 2009
Targeted therapies in the treatment of advanced/metastatic NSCLCA G Pallis, L Serfass, R Dziadziusko, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 5, 2008
The yield of endoscopic ultrasound in lung cancer staging: does lymph node size matter?Kurt G Tournoy, Frédéric De Ryck, Lieve Vanwalleghem, et al.
Pageof 25